Biotech Startups

Tracer Biotechnologies develops genomic profiling and biomarker detection solutions for oncology and cancer treatment. The company serves healthcare providers and clinical laboratories focused on precision medicine and treatment guidance.

1 investor

Tradewind Bioscience develops therapeutic antibodies for cancer, with a lead candidate targeting ovarian cancer that both attacks primary cancer cells directly and activates the immune system's anti-cancer response.

1 investor

Trailhead Biosystems develops HD-DoE (High-Dimensional Design-of-Experiments), a platform that uses computational models and control systems to differentiate human induced pluripotent stem cells (iPSCs) into specific cell types for regenerative medicine and stem cell research. The company serves stem cell researchers and cell-therapy developers with iPSC research products and differentiation technologies.

1 investor

TraitSeq provides a computational platform that integrates omics data, machine learning, and AI to help agricultural R&D teams translate field performance variations into mechanistic insights, accelerating the development of biological products. The platform serves bioinformatics, R&D, product, and leadership teams working on crop and plant optimization.

1 investor

Trames Bio is a biotech company developing gene therapies for chronic neuropathic pain, using chemogenetics to deliver an AAV-encoded inhibitory ion channel to specific pain neurons that is then activated by an oral small molecule for on-demand, reversible nerve block. Its initial focus is on trigeminal neuralgia and lumbosacral radiculopathy, with broader applications to other pain and CNS disorders.

1 investor

Transformative Biotech develops patented extraction-free direct-to-PCR chemistry that enables PCR testing directly from raw swab and saliva samples without nucleic acid purification, aiming to lower cost and speed up turnaround. The technology targets molecular diagnostics for infectious diseases and cancer, and is intended for research, clinical testing, and point-of-care use.

1 investor

TransGenex Nanobiotech (TGN Inc.) discovers and develops cancer stem cell-based diagnostic tests and drugs aimed at individualized cancer treatment. It focuses on cancer stem cell-targeting technologies for diagnostics and therapeutics in oncology.

1 investor

Transgenomic was a molecular diagnostics company that developed genetic testing platforms like WAVE and ICE COLD-PCR for cancer and inherited disease detection, and ran CLIA-certified labs.

1 investor

Transfyr builds AI and a sensor stack with multimodal models that capture a detailed record of scientific experimental work in the lab. It is aimed at scientists and research organizations to reduce variance, support automation, improve tech transfer, and train staff.

1 investor

Traphaco is a Vietnamese pharmaceutical company that produces traditional medicine and modern pharmaceuticals using contemporary technology and environmentally sustainable supply chains. The company serves healthcare communities and operates under principles linking economic growth with environmental protection and social responsibility.

1 investor

Travv develops AI-powered veterinary diagnostics, including digital pathology tools for the animal health industry. The company builds diagnostic technology aimed at advancing veterinary and anatomic pathology.

1 investor

Traws Pharma is a pharmaceutical company developing therapeutics, with a leadership focus spanning oncology, infectious disease, and medical science areas.

1 investor

Trears Biomarkers develops medical devices and biomarker platforms using earwax-based sampling to enable long-term monitoring of chronic conditions like metabolic syndrome and cardiovascular disease. The company operates at the intersection of clinical diagnostics and digital health, serving healthcare systems and clinical partners with non-invasive alternatives to point-in-time blood or saliva testing.

1 investor

Tree Flowers Solutions (TFS) researches, develops, and produces natural preservatives and tannins for the agri-food industry, with a focus on the beverage sector and particularly the wine industry. It offers extraction, water and solvent concentration, spray-drying, packaging, and freezing services, and works on natural ingredient and biobased coating projects with scientific and industry partners.

1 investor

TreeFrog develops C-Stem, a GMP-compliant technology platform for scalable production of cell therapies that optimizes yield and quality while minimizing cell damage. The platform serves biotech and cell therapy companies from early-stage research through commercial manufacturing.

1 investor

TRELEGY is a once-daily prescription inhaler used long-term to treat COPD (including chronic bronchitis and emphysema) and asthma in adults. It combines an inhaled corticosteroid, an anticholinergic, and a long-acting beta2-adrenergic agonist, and is not intended as a rescue inhaler.

1 investor

Trench Therapeutics develops live biotherapeutic products derived from research on the nasal microbiome to prevent and treat infectious and inflammatory diseases. Its approach aims to provide alternatives to antibiotic use and address antibiotic resistance.

1 investor

A biotechnology company associated with G207, an oncolytic (herpes simplex virus-based) therapy used to treat brain tumors, as illustrated by a pediatric patient treated at UAB and Children's of Alabama.

1 investor

Tres Alchemix develops AI platforms that combine quantum-level chemical calculations with multi-omics models trained on curated biochemical and pharmacological data to predict how chemicals behave in the human body, including drug properties, chemical-protein interactions, and pharmacokinetics/pharmacodynamics. The company applies these technologies to AI-driven drug development and biological research questions.

1 investor

Trevena develops and commercializes innovative pharmaceutical therapies for central nervous system disorders. The company has an FDA-approved drug (OLINVYK) and multiple investigational candidates targeting migraine, opioid use disorder, and neuropathic pain.

1 investor

TriApex provides contract research organization (CRO) services supporting pharmaceutical and biologics development, including preclinical studies, clinical trial design, regulatory strategy, and post-market safety monitoring.

1 investor

1 investor

Trialus Bioscience provides protein purification products and services for laboratory and research applications.

1 investor

Trident Bioscience develops software for protein design that uses computational models to identify candidate protein sequences and optimize them into gene libraries for rapid experimental testing. The platform aims to shorten the timeline for developing synthetic proteins.

1 investor